These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7010380)

  • 1. Can otitis media be prevented with pneumococcal vaccine?
    Mäkelä PH; Karma P
    Prog Clin Biol Res; 1980; 47():95-106. PubMed ID: 7010380
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumococcal vaccine and otitis media in infancy.
    Mäkelä PH; Karma P; Leinonen MK
    Bull Eur Physiopathol Respir; 1983; 19(2):235-8. PubMed ID: 6871501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination trials in otitis media: experiences in Finland since 1977.
    Mäkelä PH; Karma P
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S79-82. PubMed ID: 2648300
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination against pneumococci].
    Wiedermann G
    Wien Med Wochenschr; 1982 Oct; 132(20):479-84. PubMed ID: 7157810
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of Streptococcus pneumoniae and influenza virus vaccines in the chinchilla otitis media model.
    Giebink GS
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S42-4. PubMed ID: 2648295
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide.
    Giebink GS; Berzins IK; Schiffman G; Quie PG
    J Infect Dis; 1979 Nov; 140(5):716-23. PubMed ID: 43345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otitis media: prospects for prevention.
    Haggard M
    Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against acute otitis media].
    Veenhoven RH; van den Berg YL; Schilder AG; Dhooge IJ; Rijkers GT; Sanders EA
    Ned Tijdschr Geneeskd; 2000 May; 144(20):931-4. PubMed ID: 10827848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal vaccine in otitis media.
    Mäkelä PH; Karma P
    Lancet; 1981 Jan; 1(8212):152-3. PubMed ID: 6109824
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal otitis media vaccine trials.
    Klein JO
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S82-3. PubMed ID: 2648301
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of pneumococcal capsular types causing pediatric infections.
    Austrian R
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S21-2. PubMed ID: 2648289
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of new pneumococcal vaccines: the Finnish approach.
    Eskola J; Takala AK; Kilpi TM; Lankinen KS; Käyhty H
    Dev Biol Stand; 1998; 95():85-92. PubMed ID: 9855418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of pneumococcal vaccine.
    Le C
    JAMA; 2000 Jul; 284(4):440; author reply 440-1. PubMed ID: 10904499
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of antibiotic resistance for management of acute otitis media.
    Klein JO
    J Lab Clin Med; 2000 Mar; 135(3):220-4. PubMed ID: 10711859
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
    Barnett ED; Pelton SI; Cabral HJ; Eavey RD; Allen C; Cunningham MJ; McNamara ER; Klein JO
    Clin Infect Dis; 1999 Jul; 29(1):191-2. PubMed ID: 10433584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.